menu search

BFRI / Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023

Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023
WOBURN, MA / ACCESSWIRE / February 15, 2023 / Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products has been invited to present at the Third Annual Winter Wonderland - Best Ideas Virtual Investor conference, which is being held virtually on February 21st - 24th, 2023. Biofrontera, Inc. Chief Executive Officer, Erica Monaco, and Chief Financial Officer, Fred Leffler will represent the company at the conference. Read More
Posted: Feb 15 2023, 08:00
Author Name: Accesswire
Views: 102273

BFRI News  

All You Need to Know About Biofrontera Inc. (BFRI) Rating Upgrade to Buy

By Zacks Investment Research
September 18, 2023

All You Need to Know About Biofrontera Inc. (BFRI) Rating Upgrade to Buy

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might dri more_horizontal

Biofrontera Inc. (BFRI) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 11, 2023

Biofrontera Inc. (BFRI) Q2 2023 Earnings Call Transcript

Biofrontera Inc. (NASDAQ:BFRI ) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ET Company Participants Tirth Patel - Investor Relations Herm more_horizontal

Biofrontera Inc. (BFRI) Reports Q2 Loss, Lags Revenue Estimates

By Zacks Investment Research
August 11, 2023

Biofrontera Inc. (BFRI) Reports Q2 Loss, Lags Revenue Estimates

Biofrontera Inc. (BFRI) came out with a quarterly loss of $6.14 per share versus the Zacks Consensus Estimate of a loss of $5.14. This compares to los more_horizontal

Biofrontera Inc. (BFRI) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 12, 2023

Biofrontera Inc. (BFRI) Reports Q1 Loss, Misses Revenue Estimates

Biofrontera Inc. (BFRI) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.08 pe more_horizontal

Biofrontera, Inc. (BFRI) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 8, 2023

Biofrontera, Inc. (BFRI) Q4 2022 Earnings Call Transcript

Biofrontera, Inc. (NASDAQ:BFRI ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Erica Monaco - CEO, COO, Treasurer & S more_horizontal

Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023

By Accesswire
February 15, 2023

Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023

WOBURN, MA / ACCESSWIRE / February 15, 2023 / Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of de more_horizontal


Search within

Pages Search Results: